From St. Joseph Family Medicine Residency, Denver, CO (ECK); Department of Family Medicine, University of Colorado School of Medicine, Aurora, CO (AJR, MJS, DEN).
J Am Board Fam Med. 2018 Sep-Oct;31(5):805-808. doi: 10.3122/jabfm.2018.05.170462.
Medical marijuana is now permitted in most states, but it is not clear whether primary care physicians (PCPs) are aware of or recommend its use in their patients.
We distributed paired surveys to PCPs and their patients to assess the frequency of patient marijuana use and communication with PCPs about use.
Of 242 patients surveyed, 22% reported marijuana use in the past 6 months, and 61% of these identified as medical marijuana users. PCPs did not complete state forms to recommend medical marijuana for any of the surveyed medical marijuana users. PCPs were aware of marijuana use in their patients only 53% of the time. PCPs identified conditions they believed could be adversely affected by marijuana use in 31% of users.
There is poor communication between patients and PCPs about medical marijuana use, which is being sanctioned by physicians other than patients' PCPs. We suggest more frequent assessment of and discussion about marijuana use in patients, particularly in states that have approved medical marijuana.
医用大麻目前在大多数州都被允许使用，但尚不清楚初级保健医生（PCP）是否了解或建议其在患者中使用。
我们向 PCP 和他们的患者分发配对调查，以评估患者大麻使用的频率以及与 PCP 就使用情况进行沟通的频率。
在接受调查的 242 名患者中，22%的人报告在过去 6 个月中使用过大麻，其中 61%的人被认定为医用大麻使用者。PCP 没有为接受调查的任何医用大麻使用者填写州推荐表格。PCP 仅在 53%的时间了解到患者使用大麻的情况。PCP 确定他们认为在 31%的使用者中可能会受到大麻使用影响的疾病。
患者和 PCP 之间在医用大麻使用方面沟通不畅，而且这种情况是由患者的 PCP 以外的医生批准的。我们建议更频繁地评估和讨论患者的大麻使用情况，特别是在已经批准医用大麻的州。
